Ajanta Pharma: Newspaper notice on transfer of shares to IEPF
Ajanta Pharma Limited published a notice regarding the transfer of equity shares to the IEPF for unclaimed dividends over the last seven years. Shareholders must lodge claims by August 1, 2026, to avoid transfer of shares to IEPF on August 11, 2026. This action follows SEBI regulations and the Companies Act.
This is a routine compliance announcement related to unclaimed dividends and subsequent transfer of shares to IEPF. It does not directly impact the company's operations, financial performance, or strategic direction. The impact on shareholders who have unclaimed dividends is primarily procedural.
The announcement is a routine regulatory filing regarding unclaimed dividends and transfer of shares to IEPF, which is a standard procedure. It does not contain any new financial information or business updates that would significantly impact the company's valuation or outlook.
Ajanta Pharma Limited has published a newspaper notice regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF) account. This action is in accordance with Section 124(6) of the Companies Act, 2013, and relevant rules. The notice, published in Free Press Journal (English) and Navshakti (Marathi) on August 28, 2026, calls upon concerned shareholders to lodge their claims for unclaimed dividends from the company over the last seven years. Failure to do so will result in the underlying shares being transferred to the IEPF.
The company has undertaken this process as per Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholders who have not claimed their dividends for the past seven years are urged to submit their claims. The company has also informed that the unclaimed shares will be transferred to IEPF on August 11, 2026. Shareholders are advised to submit their claims by August 1, 2026, to avoid their shares being transferred to IEPF. The detailed list of shareholders and their folio numbers whose shares are proposed to be transferred to IEPF is available on the company's website, www.ajantapharma.com, and the registrar's website, www.bigshareonline.com.
A plain-language summary of a public exchange filing by Ajanta Pharma Limited. Read the original for the full detail.